Health and Fitness Health and Fitness
Thu, October 27, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific
[ Thu, Oct 27th 2011 ] - Market Wire
Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector
[ Thu, Oct 27th 2011 ] - Market Wire
PharmaGap Sets Time for in Vivo Tests
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Reports Third Quarter 2011 Financial Results
[ Thu, Oct 27th 2011 ] - Market Wire
Incyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical Programs
[ Thu, Oct 27th 2011 ] - Market Wire
Implant Sciences Explosives Detection Technology Protects Major European Bank
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)
[ Thu, Oct 27th 2011 ] - Market Wire
ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 27th 2011 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu
Wed, October 26, 2011
[ Wed, Oct 26th 2011 ] - Market Wire
CardioNet, Inc. Board of Directors Announces the .. gnation of Randy Thurman as Chairman of the Board
[ Wed, Oct 26th 2011 ] - Market Wire
OncoGenex Announces Publication of OGX-427 Pre-Clinical Data in Pancreatic Cancer
[ Wed, Oct 26th 2011 ] - Market Wire
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
[ Wed, Oct 26th 2011 ] - Market Wire
FDA Schedules Delcath Pre-New Drug Application Meeting Date
[ Wed, Oct 26th 2011 ] - Market Wire
DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
[ Wed, Oct 26th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Adolor Corp.
[ Wed, Oct 26th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of HealthSpring, Inc.
[ Wed, Oct 26th 2011 ] - Market Wire
AtriCureas Synergy Ablation System Receives a Recommendation from FDA Expert Advisors
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec maakt positieve top-line resultaten b .. zoek naar BG-12 (dimethylfumaraat) oraal voor mul
[ Wed, Oct 26th 2011 ] - Market Wire
Universal American Corp. Reports Third Quarter 2011 Results
[ Wed, Oct 26th 2011 ] - Market Wire
Critical Outcome Technologies Inc. Reports Fiscal 2012 First Quarter Financial Results
[ Wed, Oct 26th 2011 ] - Market Wire
Baxter to Present at the Credit Suisse 2011 Healthcare Conference
[ Wed, Oct 26th 2011 ] - Market Wire
Black Smoker Provides Corporate Update
[ Wed, Oct 26th 2011 ] - Market Wire
Medtronic Starts Landmark Study of Hypertension Treatment
[ Wed, Oct 26th 2011 ] - Market Wire
Quidel Receives 510(k) Clearance of Its Sofia(TM) .. t Immunoassay Analyzer and Influenza A+B FIA Test
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec anuncia importantes resultados prelim .. ensayo de fase 3 que investiga el frmaco oral BG-
[ Wed, Oct 26th 2011 ] - Market Wire
A.M. Best Comments on CIGNA Corporationas Proposed Acquisition of HealthSpring Inc.
[ Wed, Oct 26th 2011 ] - Market Wire
No Changes to Teleflex Incorporated Leadership

No Changes to Teleflex Incorporated Leadership


Published on 2011-10-26 07:02:43 - Market Wire
  Print publication without navigation


LIMERICK, Pa.--([ BUSINESS WIRE ])--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has issued a statement in response to an incorrect notice posted on the Thompson Reuters website.

The Thomson Reuters report on its website yesterday mistakenly reported that Dr. Ming S. Liu was named CEO of Teleflex Incorporated. This statement was incorrect and solely the result of Thomson Reuters error in not using the correct stock ticker symbol for Pacgen Biopharmaceuticals (TSX-V: PGA). Benson F. Smith continues in his current role as Chairman, President and CEO of Teleflex Incorporated.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,600 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at [ http://www.teleflex.com ].

Contributing Sources